Clinical Trial Update: Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating Abraxane with carboplatin, cetuximab (Erbitux) and IMRT for locally advanced squamous cell carcinoma of the head and neck; study term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenosquamous Carcinoma
• Basaloid Squamous Cell Carcinoma
• Squamous Cell Carcinoma of the Head and Neck
• Undifferentiated Carcinoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• ERBITUX (cetuximab)
• Paraplatin (Carboplatin)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Squamous Cell Carcinoma of the Head and Neck, Basaloid Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2016-12-12